Nanoform grant Global STARMAP[®] AI License to AstraZeneca
Press release Nanoform Finland Plc October 23, 2023 08:10 Finnish time / 07:10 Swedish time Nanoform grant Global STARMAP[®] AI License to AstraZeneca Helsinki, Finland – Nanoform Finland Plc. (Nanoform), an innovative nanoparticle medicine-enabling company today announced that it has granted AstraZeneca Plc a global online STARMAP[®] license. STARMAP[®] is a digital AI version of the CESS[®] technology that enables in-silico experiments to determine which molecules should be nanoformed. The license will enable AstraZeneca to screen molecules from drug discovery through to